mahita, llc – FDA Warning Letter, Aug 16, 2021
On August 19, 2021, the FDA and FTC issued a Warning Letter to PushMyCart regarding the sale of unapproved and misbranded products claiming to mitigate, prevent, treat, diagnose, or cure COVID-19. The agencies reviewed the company's website (https://www.pushmycart.com), Facebook page (https://www.facebook.com/pushmycartglobal), and Amazon storefront (PushMyCart) on August 2 and 16, 2021.
The products cited include "Patanjali Coronil Kit," "Dr. Reckeweg Arsenic Album Dilution 30 CH," "SBL Arsenicum Album Dilution 30 CH," "Kerala Ayurveda Balarishtam," and "Kottakkal Balarishtam." The FDA determined these are unapproved new drugs, violating section 505(a) of the FD&C Act (21 U.S.C. § 355(a)), and misbranded drugs under section 502 (21 U.S.C. § 352). The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)).
Examples of violative claims include "PATANJALI Corona KIT," "coronapre
ID · 487b02d4-867d-4581-b80d-810c96be86b4
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.